Virtual reality and dye for lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your lung tumor is smaller than 3 centimeters.
- You have Stage 1 Non-Small Cell Lung Cancer (a common type of lung cancer).
- CT scans show the tumor is limited to one segment of your lung, making you a candidate for segmental resection (removing just that segment).
- You are not allergic to indocyanine green, sodium iodide, or iodine.
- If you are a woman able to have children, you must be using adequate birth control and not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests whether 3D models from a CT scan without dye can help guide minimally invasive lung surgery. If you have a small early-stage lung cancer and are eligible for keyhole surgery, this study might be for you.
This trial tests a new imaging technology that uses augmented reality (like a digital map overlay) to help surgeons better identify and remove swollen lymph nodes in the neck during lung cancer surgery. The goal is to make the surgery safer and more precise.
This trial uses 3D models from your CT scan to help doctors predict how well your lungs will work after surgery. It is for people having a certain type of lung surgery (VATS) to remove part of a lung.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.